Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Issue 9 (20th June 2022) - Stensen, Signe; Krogh, Liva L.; Sparre‐Ulrich, Alexander H.; Dela, Flemming; Hartmann, Bolette; Vilsbøll, Tina; Holst, Jens J.; Rosenkilde, Mette M.; Christensen, Mikkel B.; Gasbjerg, Lærke S.; Knop, Filip K.